ArticleJournal of medical case reports2025
Magnesium sulfate toxicity successfully managed with hemodialysis: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Successful treatment of ibuprofen intoxication using hemoperfusion with porous polymeric adsorbents in a toy poodle.The Journal of veterinary medical science · 2026Article
- Magnesium sulfate pharmacology for maternal and critical-care indications: mechanisms, pharmacokinetics, and the therapeutic window.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMagnesium toxicity occurs mostly in patients with decreased renal function or in preeclamptic patients who underwent high-dose magnesium sulfate therapy. Iatrogenic injection of magnesium sulfate is a rare condition. Magnesium sulfate extensively influences heart, lung, and brain function. Therefore, it is crucial to manage magnesium sulfate overdose through intensive procedures if common treatments do not improve the patient's prognosis. Our paper focuses on a case study of a patient who overdosed on magnesium sulfate and was managed through hemodialysis. CASE PRESENTATION: A 50-year-old Iranian woman was admitted to the hospital, following the injection of two vials of magnesium sulfate (25 g each) by emergency medicine services mistakenly, instead of the vial of glucose. At the entrance of the emergency ward, she became pulseless, and they initiated cardiopulmonary resuscitation and intubation. Electrocardiogram and laboratory results showed hypermagnesemia. Primary supportive interventions-fluid therapy and calcium gluconate injections-were ineffective in halting the progression of the patient's symptoms. Therefore, we decided to initiate hemodialysis, which significantly improved the patient's symptoms. Consequently, she improved and was discharged from the intensive care unit and the hospital.
conclusionHypermagnesemia is a life-threatening and emergency condition that must be recognized and managed immediately. Hemodialysis should be considered promptly if basic supportive interventions such as calcium gluconate and fluid therapy are ineffective in treating hypermagnesemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.